| 11/10/2026 3:46 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/06/2026 4:19 PM | Carr Patricia (1784606) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/06/2026 3:41 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/05/2026 5:28 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2026 12:19 PM | FMR LLC (315066) Filed by Jazz Pharmaceuticals (1232524) Subject | Form SCHEDULE 13G/A | |
| 11/04/2026 5:35 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 3:23 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/26/2026 3:03 PM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/09/2026 8:02 AM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/08/2026 3:04 PM | Jazz Pharmaceuticals (1232524) Subject ORiordan Anne (1767870) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/07/2026 4:44 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for JAZZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/06/2026 3:20 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/05/2026 3:18 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2026 3:32 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/23/2026 3:15 PM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2026 8:06 AM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/14/2026 5:38 PM | Jazz Pharmaceuticals (1232524) Issuer Patil Neena M (1783908) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 3:28 PM | Henderson Mary Elizabeth (1989533) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 3:33 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 3:06 PM | Jazz Pharmaceuticals (1232524) Subject Patil Neena M (1783908) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/08/2026 3:37 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/08/2026 1:27 PM | Henderson Mary Elizabeth (1989533) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/02/2026 4:38 PM | Henderson Mary Elizabeth (1989533) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:06 PM | Jazz Pharmaceuticals (1232524) Issuer Winningham Rick E (1302443) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:24 PM | Hamill Laura (1751804) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:28 PM | Jazz Pharmaceuticals (1232524) Issuer LOVE TED W (1188919) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:31 PM | Jazz Pharmaceuticals (1232524) Issuer RIEDEL NORBERT G (1161662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:34 PM | Jazz Pharmaceuticals (1232524) Issuer Smith Mark Douglas (1756253) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:09 PM | Jazz Pharmaceuticals (1232524) Issuer Kennedy Patrick (2013944) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:13 PM | Jazz Pharmaceuticals (1232524) Issuer McSharry Heather Ann (1576068) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:17 PM | ENRIGHT PATRICK G (1253886) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:20 PM | Cook Jennifer E. (1754371) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 4:03 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:21 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 5:45 PM | Iannone Robert (1737329) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/31/2026 4:21 PM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/31/2026 4:04 PM | Jazz Pharmaceuticals (1232524) Subject LOVE TED W (1188919) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 3:51 PM | Jazz Pharmaceuticals (1232524) Subject Winningham Rick E (1302443) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 3:33 PM | ENRIGHT PATRICK G (1253886) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 3:14 PM | Jazz Pharmaceuticals (1232524) Subject Smith Mark Douglas (1756253) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 2:41 PM | Hamill Laura (1751804) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The investigation Porter spent tens of thousands to document (Ad) Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film.
Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. Watch the full investigation and decide for yourself |
| 08/31/2026 2:50 PM | Henderson Mary Elizabeth (1989533) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 2:26 PM | Jazz Pharmaceuticals (1232524) Subject McSharry Heather Ann (1576068) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 2:36 PM | Cook Jennifer E. (1754371) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 2:10 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/27/2026 3:31 PM | Iannone Robert (1737329) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/25/2026 3:06 PM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/10/2026 4:13 PM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/10/2026 6:40 AM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/07/2026 4:55 PM | Jazz Pharmaceuticals (1232524) Issuer LOVE TED W (1188919) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:57 PM | Jazz Pharmaceuticals (1232524) Issuer Winningham Rick E (1302443) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 5:01 PM | Jazz Pharmaceuticals (1232524) Issuer Pearce Samantha (1805688) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:39 PM | Jazz Pharmaceuticals (1232524) Issuer McSharry Heather Ann (1576068) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:42 PM | Jazz Pharmaceuticals (1232524) Issuer Mulligan Seamus (1536639) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:44 PM | Cook Jennifer E. (1754371) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:46 PM | Jazz Pharmaceuticals (1232524) Issuer Smith Mark Douglas (1756253) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:48 PM | Jazz Pharmaceuticals (1232524) Issuer Kennedy Patrick (2013944) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:50 PM | Hamill Laura (1751804) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:31 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:33 PM | Jazz Pharmaceuticals (1232524) Issuer RIEDEL NORBERT G (1161662) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 4:37 PM | ENRIGHT PATRICK G (1253886) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 1:09 PM | Jazz Pharmaceuticals (1232524) Subject ORiordan Anne (1767870) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2026 9:31 AM | FMR LLC (315066) Filed by Jazz Pharmaceuticals (1232524) Subject | Form SCHEDULE 13G | |
| 08/05/2026 3:33 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/03/2026 3:16 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/03/2026 3:06 PM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/14/2026 3:36 PM | Jazz Pharmaceuticals (1232524) Filer | Form DEFA14A | |
| 07/06/2026 5:23 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 5:27 PM | Jazz Pharmaceuticals (1232524) Issuer Pearce Samantha (1805688) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 5:09 PM | Jazz Pharmaceuticals (1232524) Issuer Patil Neena M (1783908) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 5:16 PM | Iannone Robert (1737329) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 5:21 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 5:04 PM | Jazz Pharmaceuticals (1232524) Issuer Johnson Philip L (2013156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 2:55 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/17/2026 3:45 PM | Jazz Pharmaceuticals (1232524) Issuer Smith Mark Douglas (1756253) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 3:04 PM | Jazz Pharmaceuticals (1232524) Subject Patil Neena M (1783908) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/08/2026 3:05 PM | Jazz Pharmaceuticals (1232524) Filer | Form DEF 14A | |
| 06/08/2026 3:07 PM | Jazz Pharmaceuticals (1232524) Filer | Form DEFA14A | |
| 06/05/2026 3:40 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 4:09 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 3:05 PM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2026 3:18 PM | Jazz Pharmaceuticals (1232524) Subject Pearce Samantha (1805688) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/27/2026 5:13 PM | Jazz Pharmaceuticals (1232524) Issuer Winningham Rick E (1302443) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 5:07 PM | Jazz Pharmaceuticals (1232524) Issuer McSharry Heather Ann (1576068) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 3:06 PM | Jazz Pharmaceuticals (1232524) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/01/2026 2:44 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/30/2026 10:19 AM | Jazz Pharmaceuticals (1232524) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/03/2026 4:09 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 9:20 AM | Jazz Pharmaceuticals (1232524) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/09/2026 4:21 PM | Iannone Robert (1737329) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 4:23 PM | Jazz Pharmaceuticals (1232524) Issuer Pearce Samantha (1805688) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Your book is inside (Ad) The "Sucker's Bet" Most New Options Traders Fall For
Most people who try options lose money the same way.
They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter.
Normally $29.97. Free today. Download your copy now. |
| 03/09/2026 4:25 PM | Henderson Mary Elizabeth (1989533) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 4:27 PM | Jazz Pharmaceuticals (1232524) Issuer Johnson Philip L (2013156) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 4:31 PM | COZADD BRUCE C (1193210) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 4:07 PM | Jazz Pharmaceuticals (1232524) Issuer Patil Neena M (1783908) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 4:10 PM | GALA RENEE D (1607737) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 4:15 PM | Carr Patricia (1784606) Reporting Jazz Pharmaceuticals (1232524) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 3:26 PM | Carr Patricia (1784606) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 1:48 PM | Carr Patricia (1784606) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 12:58 PM | Henderson Mary Elizabeth (1989533) Reporting Jazz Pharmaceuticals (1232524) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |